Men who take long-acting opioids for chronic pain appear to be at greater risk of developing low testosterone than men taking short-acting opioids, American researchers have found.
Testosterone replacement therapy using long-acting testosterone undecanoate (TU) improved several sexual function domains in men with type 2 diabetes, British researchers have shown.
Serum PSA levels may useful for diagnosing hypogonadism (low testosterone), Italian researchers say.
Testosterone replacement therapy (TRT) might be suitable for men with hypogonadism who also have a history of prostate cancer, but more research is needed, according to a group of Canadian and American scientists.
Laboratory testing for testosterone (T) levels should be standardized and a hypogonadism diagnosis should be made using both a blood test and a physical exam, a panel of experts says.
Men with erectile dysfunction (ED) might have increased cardiovascular risk when their testosterone levels fall below 12 nmol/L, according to a recent Journal of Sexual Medicine study.